ALVOTECH
Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacture of high-quality biosimilar medicines. The company's goal is to improve patients' health and quality of life around the world by increasing access to effective therapies for various ailments. Alvotech was established on January 1, 2013, by Róbert Wessman in Reykjavík, Gullbringusysla.
ALVOTECH
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2013-01-01
Address:
Reykjavík, Gullbringusysla, Iceland
Country:
Iceland
Website Url:
http://www.alvotech.com
Total Employee:
501+
Status:
Active
Contact:
+354 422 4500
Total Funding:
1.72 B USD
Technology used in webpage:
Domain Not Resolving IPv6 U.S. Server Location CrUX Top 10m DigiCert SSL Akamai Hosted
Similar Organizations
Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Board_member
2016-01-01
Current Employees Featured
Sarah Tanksley Chief Quality Officer @ Alvotech
Chief Quality Officer
2022-10-01
Christina Siniscalchi Interim Chief Quality Officer @ Alvotech
Interim Chief Quality Officer
2024-01-01
Anil Okay Chief Commercial Officer @ Alvotech
Chief Commercial Officer
2018-07-01
Andrew Roberts Chief Portfolio Officer @ Alvotech
Chief Portfolio Officer
2019-11-01
Joel Morales EVP & Chief Financial Officer @ Alvotech
EVP & Chief Financial Officer
2020-01-01
Sean Gaskell Chief Technical Officer @ Alvotech
Chief Technical Officer
2020-07-01
Mark Levick CEO @ Alvotech
CEO
2019-08-01
Ming Li Chief Strategy Officer @ Alvotech
Chief Strategy Officer
2020-01-01
Róbert Wessman Founder & Chairman @ Alvotech
Founder & Chairman
2013-10-01
Rakel Ottarsdottir Chief Information Officer @ Alvotech
Chief Information Officer
2020-11-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-05-19 | Baliopharm | Baliopharm acquired by Alvotech | N/A |
Investors List
Alvogen
Alvogen investment in Venture Round - Alvotech
Athos Capital
Athos Capital investment in Venture Round - Alvotech
Shinhan Capital
Shinhan Capital investment in Venture Round - Alvotech
Baxter Ventures
Baxter Ventures investment in Venture Round - Alvotech
Aztiq
Aztiq investment in Venture Round - Alvotech
Fuji Pharma
Fuji Pharma investment in Corporate Round - Alvotech
Key Employee Changes
| Date | New article |
|---|---|
| 2024-02-29 | Alvotech Appoints Interim Chief Quality Officer |
| 2022-10-11 | Alvotech Appoints Sarah Tanksley as Chief Quality Officer |
Official Site Inspections
http://www.alvotech.com Semrush global rank: 3.3 M Semrush visits lastest month: 4.27 K
- Host name: 76.76.21.164
- IP address: 76.76.21.164
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alvotech"
Company - Alvotech - Better Access Better Lives
Working for Alvotech. Moving to Iceland. Job openings. Company News. Media Gallery. Skip Navigation. About us. Creating a healthier world through affordable biologics. Who we are. We have a deep appreciation for the positive impact …See details»
Alvotech - Crunchbase Company Profile & Funding
Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacture of high-quality biosimilar medicines. The company's goal is to …See details»
Office locations - Alvotech - Better Access Better Lives
Alvotech’s international team currently includes over 400 scientists and professionals. Alvotech’s international team currently includes over 400 scientists and professionals. 01 Company. About us. Culture and Values. Leadership. …See details»
Alvotech Corporate Overview
Between Alvotech Holdings S.A., Oaktree Acquisition Corp. II and Alvotech; (2) the ability to maintain stock exchange listing standards; (3) changes in applicable laws or regulations; (4) …See details»
Alvotech - Overview, News & Similar companies | ZoomInfo.com
Alvotech is a privately-owned biopharmaceutical company focused on the development and manufacturing of high quality biosimilars for global markets. They are specialists in …See details»
Alvotech Acquires Xbrane’s R&D Operations in Sweden and …
Mar 20, 2025 Alvotech also announced that it intends to explore the possibility of a listing of Swedish Depository Receipts (SDR), equity share equivalents, on Nasdaq Stockholm, in the …See details»
Alvotech - Funding, Financials, Valuation & Investors - Crunchbase
Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How …See details»
Alvotech - AnnualReports.com
Alvotech is a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Their mission is to improve patient lives and the …See details»
Alvotech Company Profile - Office Locations, Competitors ... - Craft
Alvotech is a biopharmaceutical company focused on the creation of biosimilar medicines. It is engaged in the development and manufacture of biosimilar monoclonal antibodies for the …See details»
Alvotech Reports Record Results for 2024 and Provides Business …
2 days ago Alvotech will conduct a business update conference call and live webcast on Thursday March 27, 2025, at 8:00 am ET (12:00pm GMT). REYKJAVIK, Iceland, March 26, …See details»
Alvotech (ALVOW) Company Profile & Overview - Stock Analysis
Mar 4, 2025 Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, …See details»
Alvotech: Governance, Directors and Executives & Committees ...
1 day ago Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in …See details»
Alvotech (ALVO) Company Profile & Facts - Yahoo Finance
See the company profile for Alvotech (ALVO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
ESG Portal - Alvotech - Better Access Better Lives - Alvotech
Alvotech is committed to the promise of biosimilars, which we believe can directly expand patient access to medicines globally and contribute to the overall sustainability of healthcare systems …See details»
Alvotech: history, ownership, mission, how it works & makes money
A Who Owns Alvotech. Alvotech Holdings is an innovative biotechnology firm primarily focused on developing biosimilar treatments. The company is publicly traded on the Nasdaq under the …See details»
Alvotech Reports Record Results for 2024 and Provides Business …
1 day ago Alvotech will conduct a business update conference call and live webcast on Thursday March 27, 2025, at 8:00 am ET (12:00pm GMT). Alvotech (NASDAQ: ALVO, or the …See details»
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
22 hours ago Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients …See details»
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic …
Mar 18, 2025 HYDERABAD, India and REYKJAVIK, Iceland, March 18, 2025 (GLOBE NEWSWIRE) -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, …See details»
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy
22 hours ago Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products, and services, enabled by a fully integrated approach and …See details»
Our culture - Alvotech - Better Access Better Lives
At Alvotech, we specialize in biosimilars and love what we do. We are a team of over 1000 professionals, living and working in multiple countries, united by our commitment to improving …See details»